Human decidual gamma/delta T cells possess unique effector and TCR repertoire profiles during pregnancy.


Journal

Cellular immunology
ISSN: 1090-2163
Titre abrégé: Cell Immunol
Pays: Netherlands
ID NLM: 1246405

Informations de publication

Date de publication:
12 2022
Historique:
received: 24 05 2022
revised: 21 08 2022
accepted: 19 10 2022
pubmed: 30 10 2022
medline: 7 12 2022
entrez: 29 10 2022
Statut: ppublish

Résumé

Human γδ T cells are enriched at the maternal-fetal interface (MFI, decidua basalis) showing a highly differentiated phenotype. However, their functional potential is not well-known and it is not clear whether this decidua-enrichment is associated with specific γδ T cell receptors (TCR) as is observed in mice. Here we addressed these open questions by investigating decidual γδ T cells during early and late gestation, in comparison with paired blood samples, with flow cytometry (cytotoxic mediators, cytokines) and TCR high-throughput sequencing. While decidual γδ T cells expressed less perforin than their counterparts in the blood, they expressed significant more granulysin during early pregnancy. Strikingly, this high granulysin expression was limited to early pregnancy, as it was reduced at term pregnancy. In contrast to this granulysin expression pattern, decidual γδ T cells produced reduced levels of IFNγ and TNFα (compared to paired blood) in early pregnancy that then increased by term pregnancy. TCR repertoire analysis indicated that human decidual γδ T cells are not generated early in life as in the mouse. Despite this, a specific enrichment of the Vγ2 chain in the decidua in early pregnancy was observed that disappeared later onwards, reflecting dynamic changes in the decidual γδ TCR repertoire during human gestation. In conclusion, our data indicate that decidual γδ T cells express a specific and dynamic pattern of cytotoxic mediators, Th1 cytokines and TCR repertoire suggesting an important role for these unconventional T cells in assuring a healthy pregnancy in human.

Identifiants

pubmed: 36308817
pii: S0008-8749(22)00159-9
doi: 10.1016/j.cellimm.2022.104634
pii:
doi:

Substances chimiques

Receptors, Antigen, T-Cell, gamma-delta 0
Cytokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104634

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

D Manchorova (D)

Institute of Biology and Immunology of Reproduction "Acad. K. Bratanov", Bulgarian Academy of Sciences, Sofia 1113, 73 Tzarigradsko shosse blv, Bulgaria.

M Papadopoulou (M)

Department of Pharmacotherapy and Pharmaceutics, Universite Libre de Bruxelles (ULB), 1050 Brussels, Belgium.

M Alexandrova (M)

Institute of Biology and Immunology of Reproduction "Acad. K. Bratanov", Bulgarian Academy of Sciences, Sofia 1113, 73 Tzarigradsko shosse blv, Bulgaria.

V Dimitrova (V)

Medical University, University Obstetrics and Gynecology Hospital "Maichin Dom", Sofia 1463, 2 Zdrave Str., Bulgaria.

L Djerov (L)

Medical University, University Obstetrics and Gynecology Hospital "Maichin Dom", Sofia 1463, 2 Zdrave Str., Bulgaria.

S Zapryanova (S)

Institute of Biology and Immunology of Reproduction "Acad. K. Bratanov", Bulgarian Academy of Sciences, Sofia 1113, 73 Tzarigradsko shosse blv, Bulgaria.

P Dimitrova (P)

Institute of Microbiology "Acad. St. Angelov", Bulgarian Academy of Sciences, Sofia 1113, 25 Acad. G. Bonchev str., Bulgaria.

I Vangelov (I)

Institute of Biology and Immunology of Reproduction "Acad. K. Bratanov", Bulgarian Academy of Sciences, Sofia 1113, 73 Tzarigradsko shosse blv, Bulgaria.

D Vermijlen (D)

Department of Pharmacotherapy and Pharmaceutics, Universite Libre de Bruxelles (ULB), 1050 Brussels, Belgium; Institute for Medical Immunology, Universitȇ Libre de Bruxelles (ULB), 6041 Gosselies, Belgium; ULB Center for Research in Immunology (U-CRI), Universite Libre de Bruxelles (ULB), Belgium; Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Wavre, Belgium.

T Dimova (T)

Institute of Biology and Immunology of Reproduction "Acad. K. Bratanov", Bulgarian Academy of Sciences, Sofia 1113, 73 Tzarigradsko shosse blv, Bulgaria. Electronic address: tanyadimova@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH